Direct-to-consumer stem cell marketing in Canada
Future Medicine - 26-Sep-2018Direct-to-costumer marketing of stem cell interventions tend to minimize risk and make bold claims without scientific support
Join the club for FREE to access the whole archive and other member benefits.
Associate Professor at University of Minnesota
Leigh Turner is an Associate Professor at the University of Minnesota Center for Bioethics, School of Public Health, and College of Pharmacy. With co-editors Jill Hodges and Ann Marie Kimball, Turner edited Risks and Challenges in Medical Tourism: Understanding the Global Market for Health Services (Praeger, 2012). With Raymond De Vries, Kristina Orfali, and Charles Bosk, Turner edited The View from Here: Bioethics and the Social Sciences (Wiley-Blackwell, 2007). Turner’s research addresses ethical, legal, and regulatory issues associated with clinics engaged in direct-to-consumer marketing of unproven and unlicensed cell-based interventions. Turner is also the author of numerous publications examining ethical issues related transnational medical travel (also known as “medical tourism”) and globalization of health care.
Visit website: https://www.pharmacy.umn.edu/bio/pharmaceutical-care-health-sys/leigh-turner
See also: University of Minnesota - Public Research university.
Details last updated 08-Feb-2019
Leigh Turner explains how to make informed choices when shopping for stem cell treatments
Direct-to-costumer marketing of stem cell interventions tend to minimize risk and make bold claims without scientific support